NanoViricides begins Phase II trial of NV-387 for mpox treatment amid WHO’s extended global emergency, addressing urgent needs in Africa and biosecurity threats.Read More
Mpox Antiviral Drug Trial Advances as WHO Extends Global Emergency
Related Posts
Add A Comment
